Personal Finance

Conducting a thorough financial examination may help clinicians to see their finances as clearly as their patients see the world after cataract surgery.

Financial experts point out that what you don’t know you don’t know can hinder you.

There are strategies you can implement to protect part of your portfolio against downside moves. This is like having a sword in one hand and a shield in the other.

One of the most stressful aspects of retirement can be transitioning from earning income to relying upon investments and other possible income sources to meet income needs.

Here's an overview of what the current world economic issues mean for today's investors.

Goal-based retirement planning is different from longevity planning.

John J. Grande, CFP, and John S. Grande, CFP, discuss why ophthalmologists should be focusing on having a financial plan ahead of a second wave in the ongoing pandemic.

Robert Freedland, MD, who works at Mayo Clinic Health System in La Crosse, Wis., is a stock market investor for the past 43 years.

The chief medical editor reflects on stocks, retirement and careers in research.

Understand exchange-traded funds and why you may want one.

Getting in and out of a mutual fund at the wrong time is generally accounted for by the psychology behind an investor's behavior.

The upheaval in our current economy is changing the ground rules for skillful handling of personal finances. Some of the time-honored methods for building and maintaining a secure financial future for you and your family need to be modified while today's unpredictable financial crisis runs its course. Here are seven tips from the experts that will help you to come out on top once the financial storm has abated.

Planning for retirement may seem like a daunting task, but physicians who have a good understanding of the basic instruments of investing-stocks and bonds-need not worry.

Q Could you explain whether it is generally better to take Social Security benefits at 62 or wait until 65 or even 70?

When considering whether to take advantage of this law, consult your financial planner.

If you're like many busy professionals in practice, you don't pay much attention to income taxes until the filing deadline looms.

The simplest way to cope with risk is to shift the risk to an insurance company. This should be your first line of defense. Before you do anything else, review your existing coverage.

For those in the know, the AMT has become the tax equivalent of the boogeyman. Unfortunately, unlike the object of children's nightmares, this lurking threat is all too real. Calculated alongside ordinary income tax for all households, the AMT erases many standard deductions to which Americans have become accustomed. Taxpayers then must pay whichever tax is higher.

The president, president-elect, and executive vice president of the American Academy of Ophthalmology (AAO) recently offered a "state-of-the-profession" message during the opening session of the AAO annual meeting in Chicago. All three executives shared in a celebration of past achievements, current conditions, and future opportunities in ophthalmology

Paris—Fovea Pharmaceuticals SA, a biopharmaceutical company working to discover, develop, and commercialize drugs to treat retinal diseases, announced the closing of a $25 million equity financing round.

If you're inclined to let your accountant do all the worrying about your professional and personal income taxes, you could be making a costly mistake.

Doctors have clearly discovered the lure of pre-tax savings, and are making the most of opportunities to sock away as much as they can.

Alpharetta, GA—When the global management of Novartis decided to shut down its ophthalmic operations in Duluth, GA, in early 2003 and relocate to New Jersey, Dan Myers, then president of Novartis Ophthalmics/North America, thought he would leave the company and have the next 6 months to relax.

Montreal—Intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) is effective in the treatment of macular diseases but is associated with complications such as ocular hypertension, endophthalmitis, intraocular inflammation, and progression of cataract. While the long-term effects of the drug still need to be determined, the drug appears to be safe for treating macular diseases.